Search Results
Results 251 - 300 of 1898
< 1 2 3 4 5 6 7 8 9 10 11 >
Keyes Mira - - 2009
PURPOSE: To describe the late transient worsening of urinary symptoms ("urinary symptom flare") in 712 consecutive prostate brachytherapy patients, associated predictive factors, association with rectal and urinary toxicity, and the development of erectile dysfunction. METHODS AND MATERIALS: Patients underwent implantation between 1998 and 2003 (median follow-up, 57 months). International Prostate ...
Hai Mahmood A - - 2009
OBJECTIVES: To evaluate the 5-year clinical outcomes and durability of photoselective vaporization of the prostate (PVP) in the treatment of benign prostatic hyperplasia with obstruction. METHODS: The patient outcomes were evaluated at 5 years for the first 321 patients who had undergone PVP from November 2000 to June 2003 at ...
Teloken Patrick E - - 2009
INTRODUCTION: Phosphodiesterase type 5 inhibitor (PDE5) use is a treatment strategy for prostate cancer patients with post-radiation therapy (RT) erectile dysfunction (ED). AIM: To define the predictors of sildenafil response in men treated with RT for prostate cancer. MAIN OUTCOME MEASURES: International Index of Erectile Function (IIEF). METHODS: Patients were ...
Jeong Young Beom - - 2009
OBJECTIVES: To investigate the change in prostate volume and symptoms after discontinuation of 5alpha-reductase inhibitors (5ARIs) in men with moderate to severe symptoms due to benign prostatic hyperplasia (BPH). METHODS: A total of 120 patients with BPH were enrolled from December 2004 to May 2008. The patients were randomized into ...
Chen Wei - - 2009
BACKGROUND AND OBJECTIVE: Androgen blockade is the principle strategy in the treatment of advanced prostate cancer. Impaired glucose tolerance often occurs in those patients after androgen blockade. This study was to investigate the correlation of insulin resistance to intermittent androgen blockade (IAB) or continuous androgen blockade, which is also named ...
Cai Tommaso - - 2009
We report the results of a prospective randomised study to evaluate the therapeutic effect of Serenoa repens, Urtica dioica (ProstaMEV), quercitin and curcumin (FlogMEV) extracts associated with prulifloxacin in patients affected by chronic bacterial prostatitis (CBP). From a whole population of 284 patients, 143 patients affected by CBP [National Institutes ...
Bach T - - 2009
PURPOSE: Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates. ...
Khera Mohit - - 2009
INTRODUCTION: Controversy exists regarding testosterone replacement therapy (TRT) in men following radical prostatectomy (RP). Many clinicians are hesitant to offer patients TRT after an RP, out of concern that the increased androgen levels may promote tumor progression or recurrence from residual tumor. Recently, several small studies have demonstrated the use ...
Buse Stephan - - 2009
PURPOSE: The potassium-titanyl-phoshate laser (KTP laser) device produces light (wavelength of 532 nm) that is absorbed by haemoglobin, thus releasing thermal energy. This reaction causes vaporization of the tissue. We tested whether preoperative haemoglobin concentrations (Hb) affect the efficiency of the 80 W KTP laser, thus affecting the energy applied. ...
Mavuduru R M - - 2009
OBJECTIVES: We conducted this study to compare the safety and efficacy of transurethral resection of the prostate (TURP) and holmium laser prostatectomy. METHODS: A total of 30 patients eligible for surgery for symptomatic benign prostatic hyperplasia were included in the study. They were randomized into two groups of 15 each. ...
Sekita Nobuyuki - - 2009
Our objective was to determine the incidence of inguinal hernia (IH) after surgery for prostatic diseases. Medical records of 395 patients who underwent radical retropubic prostatectomy (RRP; n = 155), open simple prostatectomy (OP; n = 35), or transurethral resection of the prostate (TURP; n = 205) at the Chibaken ...
Lundstr??m Eija A - - 2009
BACKGROUND AND OBJECTIVES: Triptorelin 6-month formulation was developed to offer greater convenience to both patients and physicians by reducing the injection frequency. The efficacy, pharmacokinetics and safety of a new 6-month formulation of triptorelin were investigated over 12 months (48 weeks). The primary objective was to evaluate the formulation in ...
Schelin Sonny - - 2009
OBJECTIVE: Transurethral resection of the prostate (TURP) has been the gold standard for treatment of obstructive benign prostatic hyperplasia since the 1970s. Intraprostatic injections of mepivacain epinephrine (ME) (Carbocain-Adrenalin) before Core Therm (Prostalund feedback treatment) have been used to anaesthetize the gland and reduce the intraprostatic blood flow, thereby reducing ...
Kuo Hann-Chorng - - 2009
OBJECTIVE: Botulinum toxin A (BoNT-A) injections into the prostate have been reported to be effective and durable in the treatment of small benign prostatic hyperplasia (BPH). This study evaluated the effectiveness of BoNT-A in patients with large BPH with an unsatisfactory response to combined alpha-blocker and 5-alpha-reductase inhibitor therapy. MATERIAL ...
McCullough T Casey - - 2009
PURPOSE: To evaluate the morbidity between laparoscopic simple prostatectomy (LSP) and open simple prostatectomy (OSP) in the management of benign prostatic hyperplasia. PATIENTS AND METHODS: From January 2003 through January 2008, 280 consecutive patients underwent adenomectomy either by an extraperitoneal laparoscopic transcapsular "Millin" approach (96 patients, 34.3%) or open transvesical ...
Daly Pádraig - - 2009
OBJECTIVES: To assess for predictors of outcome in patients presenting with acute urinary retention (AUR). METHODS: A study was performed in our unit to evaluate trial without catheter (TWOC) and successive management. We assessed for predictors of surgical or medical management, which included: age, volume drained at time of catheterisation, ...
Hille Andrea - - 2009
OBJECTIVE: Acute proctitis and chronic radiation proctitis are relevant complications of pelvic radiation. The purpose of this study was to investigate two markers of gut inflammation during and after irradiation for prostate cancer to evaluate a correlation between acute and chronic proctitis. MATERIAL AND METHODS: Two patient groups were analysed. ...
Guru Khurshid A - - 2009
BACKGROUND AND PURPOSE: The apex is the most common site of an involved surgical margin after robot-assisted radical prostatectomy. We assessed the impact of two surgical techniques for dorsal vein control on surgical margins rates. PATIENTS AND METHODS: From August 2005 to January 2008, 480 patients underwent robot-assisted radical prostatectomy ...
Ronquist Gunnar - - 2009
OBJECTIVE: A prior report suggested that individuals medicated with captopril showed a decreased incidence of prostate cancer. This study therefore investigated whether captopril given postoperatively had any preventive effect on biochemical recurrence for patients treated with radical prostatectomy. MATERIAL AND METHODS: Data were prospectively reviewed for 62 men subjected to ...
Perimenis Petros - - 2009
INTRODUCTION: Erectile dysfunction (ED) is a self-reported condition and satisfaction with sexual performance is individual, subjective, and multi-factorial. Treatment success depends on several outcomes. Tadalafil is a long-acting, selective inhibitor of phosphodiesterase 5 that has been shown to be effective at treating men with ED. AIM: To investigate patient's ED ...
Soleimani Mohammad - - 2009
OBJECTIVE: The occurrence of erectile dysfunction (ED) in patients who have undergone prostatectomy has been assessed in the previous studies; however, its rate and risk factors vary in different studies. This study was conducted to assess the possible risk factors for ED after prostatectomy. MATERIAL AND METHODS: In total, 246 ...
Leonardi R - - 2009
This study examined efficacy and safety of the 980 nm side-firing diode laser operating at a power of 100 W in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Patients were selected for surgery on the basis of maximum urinary flow rate (Qmax) <or=15 ml/s or ...
Knutson Tomas - - 2009
OBJECTIVE: To investigate the effects of intraprostatic mepivacaine epinephrine injections administered by the Schelin catheter during high-energy transurethral microwave thermotherapy (TUMT) using the CoreTherm Prostalund Feedback Treatment (PLFT) system. MATERIAL AND METHODS: The study included 85 men with lower urinary tract symptoms due to benign prostatic enlargement. One group had ...
Chen Qi - - 2009
OBJECTIVES: We report our prospective clinical result of transurethral resection in saline (TURIS) versus monopolar transurethral resection of the prostate (TURP) system in treating large-volume benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: Patients with BPH (volume >50 ml) were enrolled in the study. An intravenous device was used for serum ...
Park Dong Soo - - 2009
Purpose. To determine the effect of simple use of suppository povidone-iodine on infectious complications after transrectal ultrasonography-guided biopsy of the prostate. Methods. All 481 patients are included and received antibiotic prophylaxis. Among them, 360 patients received povidone-iodine suppository (Gynobetadine; 200 mg) immediately prior to biopsy and 121 patients did not. ...
Capodice Jillian L - - 2009
Subjects diagnosed with high-grade prostatic intraepithelial neoplasia (HGPIN) at biopsy are at increased risk for developing prostate cancer (CaP). A prospective clinical trial was done to determine the safety and tolerability of a novel herbal amalgam, Zyflamend (New Chapter, Inc., Brattleboro, VT), with various dietary supplements in subjects with HGPIN. ...
Mikkola Arto - - 2009
OBJECTIVE: To develop three prognostic groups for disease specific mortality based on the binary classified pretreatment variables age, haemoglobin concentration (Hb), erythrocyte sedimentation rate (ESR), alkaline phosphatase (ALP), prostate-specific antigen (PSA), plasma testosterone and estradiol level in hormonally treated patients with metastatic prostate cancer (PCa). MATERIAL AND METHODS: The present ...
Shrimali Pritesh - - 2009
OBJECTIVES: Patients with raised serum prostate-specific antigen and/or an abnormal-feeling prostate were subjected to transrectal ultrasound-guided prostatic biopsy to rule out any prostatic malignancy. There are many methods for pain relief and to treat discomfort during the procedure but we compared the efficacy of intravenous (IV) midazolam for pain control. ...
Tiong H Y - - 2009
OBJECTIVE: To compare the efficacy of Alfuzosin XL 10 mg once daily for the acute management of acute urinary retention (AUR) with placebo in patients with benign prostatic hyperplasia (BPH) and to determine the predictors that impact this. METHODS: 67 patients presenting with an initial episode of spontaneous AUR secondary ...
Silva João - - 2009
Botulinum Toxin Type-A (BoNT/A) intraprostatic injection can induce prostatic involution and improve LUTS and urinary flow in patients with Benign Prostatic Enlargement (BPE). However, the duration of these effects is unknown. The objective of this work was to determine the duration of prostate volume reduction after one single intraprostatic injection ...
Bradford Timothy J - - 2010
Preservation of periprostatic neurovascular tissue at the time of radical prostatectomy has been correlated with subsequent erectile function and urinary continence. We evaluated whether the amount of neurovascular tissue identified on prostatectomy specimens correlated with surgeon's intention of nerve-sparing and/or predicted quality of life outcomes. Radical prostatectomy specimens from 60 ...
Martin Aaron D - - 2009
OBJECTIVE: To evaluate retrospectively whether or not previous treatment to the prostate alters the perioperative outcomes from robot-assisted radical prostatectomy (RARP) after the initial 'learning curve', as there are conflicting data on outcomes of RP in patients with previous treatment to the prostate. PATIENTS AND METHODS: We retrospectively reviewed the ...
Glickman Leonard - - 2009
PURPOSE: There is a paucity of information on changes in continence and erectile function beyond 2 years after radical prostatectomy. We prospectively examined changes in continence and erectile function between 2 and 4 years after radical prostatectomy. MATERIALS AND METHODS: Between October 2000 and August 2003, 731 consecutive men underwent ...
Giannarini Gianluca - - 2009
PURPOSE: To our knowledge the optimal analgesia during prostate biopsy remains undetermined. We tested the efficacy and safety of combined perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block during transrectal ultrasound guided prostate biopsy. MATERIALS AND METHODS: A total of 280 patients were randomized to receive combined perianal-intrarectal lidocaine-prilocaine cream and ...
Namiki Shunichi - - 2009
OBJECTIVES: To measure health-related quality of life (HRQOL) after radical prostatectomy (RP) in Japanese men with localized prostate cancer. METHODS: A total of 154 patients who underwent RP were included in this 5-year longitudinal survey. The Short Form 36-Item Health Survey, the University of California, Los Angeles, Prostate Cancer Index ...
Doo Chin Kyung - - 2009
OBJECTIVES: To determine whether the anatomic configuration of the prostate, including the intravesical prostatic protrusion (IPP), as assessed by noninvasive ultrasonography, can predict the voiding parameters in men aged > or = 50 years who present with lower urinary tract symptoms. METHODS: We assessed 157 consecutive men aged > or ...
Briffaux Raphaël - - 2009
OBJECTIVE: To compare the incidence of infective events between a single dose and 3-day antibiotic prophylaxis for transrectal ultrasonography (TRUS)-guided prostate biopsy. PATIENTS AND METHODS: Patients were randomized to receive either one preoperative dose consisting of two ciprofloxacin 500 mg tablets 2 h before prostate biopsy, or 3 days of ...
Schroeck Florian R - - 2008
BACKGROUND: Both the 5-item short version of the International Index of Erectile Function (IIEF-5) and the Expanded Prostate Cancer Index Composite (EPIC) have been used to assess erectile function. In this study, the authors compared various definitions of potency according to the IIEF-5 and the EPIC. METHODS: Patients with prostate ...
Rodriguez Esequiel E - - 2009
PURPOSE: To identify surgeon specific factors for preserving sexual function (and minimize patient related factors) we report 2-year potency outcomes in men 65 years or younger with normal preoperative sexual function undergoing nerve sparing robot assisted laparoscopic radical prostatectomy. MATERIALS AND METHODS: Between July 2004 and February 2006, 200 consecutive ...
Brisinda Giuseppe - - 2009
OBJECTIVES: To present a comprehensive experience with intraprostatic botulinum toxin (BT) injection in men with symptomatic benign prostatic hyperplasia (BPH). METHODS: In this open-label study using an outpatient setting, 77 men with BPH received 200 intraprostatic BT A units (Botox) using an ultrasound-guided transperineal approach. We evaluated the American Urological ...
Mierzwa Michelle L - - 2008
BACKGROUND: Acute urinary retention is a potential complication of brachytherapy, with the literature estimating that 5% to 22% of patients require catheterization within 48 hours after implantation. In theory, postimplantation edema could be reduced by using intraoperative steroids. A prospective trial was conducted randomizing patients to a single intraoperative dose ...
Lourenco T - - 2008
To determine the clinical effectiveness and cost utility of procedures alternative to TURP (transurethral resection of the prostate) for benign prostatic enlargement (BPE) unresponsive to expectant, non-surgical treatments. Electronic searches of 13 databases to identify relevant randomised controlled trials (RCTs). Two reviewers independently assessed study quality and extracted data. The ...
Elzayat Ehab A - - 2009
OBJECTIVES: To evaluate the safety and efficacy of holmium laser enucleation of the prostate in patients with small to moderate size prostate. METHODS: We retrospectively reviewed the data of 224 patients with a preoperative prostate size </=60 cm(3), who had undergone holmium laser enucleation of the prostate at our institution ...
Jaffe Jamison - - 2009
OBJECTIVES: To evaluate the results of robot-assisted laparoscopic prostatectomy (RALP) at a high-volume conventional laparoscopic radical prostatectomy (LRP) center, to determine whether a learning curve still exists. MATERIAL AND METHODS: A total of 293 consecutive men underwent RALP between May 2000 and November 2006. We prospectively collected and reviewed patient ...
Nielsen Matthew E - - 2008
PURPOSE: Recent anatomical studies have shown that branches of the cavernous nerves running adjacent to the prostate at the apex travel more anteriorly than previously recognized. Outcomes of robot assisted radical prostatectomy suggest improved postoperative sexual outcomes following high anterior release of the levator fascia. We prospectively evaluated the effect ...
Miyazaki Hiroo - - 2008
BACKGROUND: Tiotropium is widely used for the treatment of chronic obstructive pulmonary disease (COPD), but it is not usually prescribed for patients with micturition disorder, such as benign prostatic hyperplasia (BPH), because of the potential to increase the risk of acute urinary retention through its anticholinergic effects. However, no data ...
Travassos J - - 2008
PURPOSE: Wide variations exist in the methods for reporting potency following radical prostatectomy. In this group we used a validated questionnaires pre and post operatively to access relative return to normal sexual function after bilateral nerve-sparing visual laser ablation radical prostatectomy (VLAP). MATERIALS AND METHODS: One hundred and twenty four ...
Stolzenburg Jens-Uwe - - 2008
INTRODUCTION: Review of experience with endoscopic extraperitoneal radical prostatectomy (EERPE) for localized prostate cancer. PATIENTS AND METHODS: 2000 patients underwent EERPE. Mean age of the patients was 63.2 (41-77) years. Mean preoperative PSA was 10.2 ng/ml (0.64-82 ng/ml). 601 patients had undergone previous surgery. The functional and oncological outcomes were ...
Spaliviero Massimiliano - - 2008
INTRODUCTION AND OBJECTIVE: We evaluate the safety and efficacy of catheter-free LBO laser PVP for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). METHODS: We prospectively evaluated our initial LBO laser PVP experience and the need for urethral catheterization. RESULTS: Seventy consecutive patients were ...
Pandit R K - - 2008
OBJECTIVES: To analyze current practice of management of acute urinary retention (AUR) in men above 40 years of age at B.P.Koirala Institute of Health Sciences, Nepal. MATERIALS AND METHODS: A total of 68 patients (aged 50-91 years) presenting with indwelling catheter for AUR were included in the study. Because of ...
< 1 2 3 4 5 6 7 8 9 10 11 >